Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Primary Brain Tumors|Metastatic Malignant Neoplasm to Brain
Interventions: DRUG: 4-Demethyl-4-cholestryloxycarbonylpenclomedine
Sponsor: DEKK-TEC, Inc.
Collaborators: Tulane University Medical Center, New Orleans, LA|Icahn School of Medicine at Mount Sinai|Detroit Clinical Research Center, Farmington Hills, Lansing and Owasso, MI|National Cancer Institute (NCI)|Ochsner Health System|The University of Texas Health Science Center, Houston